We are live on
!
Find out more
FDCC
Foster Dykema Cabot & Co Portfolio holdings
AUM
$827M
1-Year Est. Return
18.87%
This Fund
S&P 500
This Quarter
Est. Return
-0.12%
1 Year Est. Return
+18.87%
3 Year Est. Return
+34.03%
5 Year Est. Return
+67.09%
10 Year Est. Return
+162.67%
AUM
$412M
AUM Growth
-$6.26M
(-1.5%)
Cap. Flow
-$3.53M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
55.13%
Holding
93
New
5
Increased
18
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.47M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$489K |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$442K |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$429K |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$374K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$4.71M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06M |
| 3 |
SPDR Gold Trust
GLD
|
+$373K |
| 4 |
Johnson & Johnson
JNJ
|
+$370K |
| 5 |
NOV
NOV
|
+$350K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.63% |
| 2 | Technology | 15.48% |
| 3 | Energy | 10.01% |
| 4 | Healthcare | 5.86% |
| 5 | Consumer Staples | 3.71% |
Similar funds
FBA
MAM
IWP
DBT
CCA
FMAEN1
WWM
RWA
Foster Dykema Cabot & Co's Q3 2014 Portfolio in Review
As of Q3 2014, Foster Dykema Cabot & Co held 93 positions worth $412M, down 1.5% from $418M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Foster Dykema Cabot & Co's Q3 2014 filing shows 5 new, 18 increased, 21 reduced and 2 closed positions. Its largest new stake was iShares Russell 1000 Growth ETF: 19,292 shares worth $442K. The largest sale was Bausch Health, an estimated $4.71M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Energy.
- Foster Dykema Cabot & Co's largest Q3 2014 buy was iShares Russell 1000 Growth ETF: 19,292 shares worth $442K.
- Foster Dykema Cabot & Co added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $1.47M increase.
- Foster Dykema Cabot & Co's biggest Q3 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $1.06M.
- Foster Dykema Cabot & Co fully exited Bausch Health in Q3 2014, selling an estimated $4.71M.
- Foster Dykema Cabot & Co's ten largest holdings make up 55% of its $412M portfolio in Q3 2014.
- Foster Dykema Cabot & Co opened 5 new positions and closed 2 in Q3 2014.
- Foster Dykema Cabot & Co's portfolio value fell 1.5% quarter-over-quarter to $412M.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2014, filed 3 Nov 2014.